Literature DB >> 22048770

Virally-induced upregulation of heparan sulfate on B cells via the action of type I IFN.

Nadine Jarousse1, Damian L Trujillo, Sarah Wilcox-Adelman, Laurent Coscoy.   

Abstract

Cell surface heparan sulfate (HS) is an important coreceptor for many cytokines, chemokines, and growth factors. In this study, we report that splenic murine B cells express very little HS and that upon infection with either gammaherpesvirus (murine gammaherpesvirus 68) or betaherpesvirus (murine cytomegalovirus), HS is rapidly upregulated at the surface of B cells. HS upregulation was not observed in mice deficient for the type I IFN (IFN-I) receptor. Additionally, treatment of wild-type mice with the IFN-I inducer polyinosine polycytidylic acid triggered HS expression at the B cell surface. Similarly, incubation of purified splenic B cells with IFN-I, TLR ligands, or BCR stimulators ex vivo resulted in a drastic increase in HS surface expression. We found that IFN-I induced an increase in the surface expression of HS-modified syndecan 4 as well as that of an unidentified heparan sulfate proteoglycan. Finally, IFN-I treatment increased B cell responsiveness to APRIL, a cytokine involved in B cell survival and T cell-independent B cell responses. Enzymatic removal of HS from IFN-I-treated B cells inhibited APRIL. Altogether, our results indicate that upon herpesvirus infection in mice, HS is rapidly upregulated at the surface of B cells due to the action of IFN-I, potentially increasing B cell responsiveness to cytokines. Induction of HS expression at the B cell surface by stimulators of the innate immune response likely plays a key role in the development of a robust immune response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22048770      PMCID: PMC3677732          DOI: 10.4049/jimmunol.1003495

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes.

Authors:  Y Yamashita; K Oritani; E K Miyoshi; R Wall; M Bernfield; P W Kincade
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

Review 2.  Functions of heparan sulfate proteoglycans in cell signaling during development.

Authors:  Xinhua Lin
Journal:  Development       Date:  2004-12       Impact factor: 6.868

Review 3.  Proteoglycans: master regulators of molecular encounter?

Authors:  A D Lander
Journal:  Matrix Biol       Date:  1998-11       Impact factor: 11.583

4.  Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection.

Authors:  B M Dutia; D J Allen; H Dyson; A A Nash
Journal:  Virology       Date:  1999-09-01       Impact factor: 3.616

Review 5.  The role of APRIL and BAFF in lymphocyte activation.

Authors:  Pascal Schneider
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

6.  Syndecan captures, protects, and transmits HIV to T lymphocytes.

Authors:  Michael D Bobardt; Andrew C S Saphire; Hsiu-Cheng Hung; Xiaocong Yu; Bernadette Van der Schueren; Zhe Zhang; Guido David; Philippe A Gallay
Journal:  Immunity       Date:  2003-01       Impact factor: 31.745

7.  Polygenic control of interferon production induced by poly I:C in vivo. Brief report.

Authors:  A Pugliese; D Cortese; G Forni
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

8.  Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors.

Authors:  Sheila Dias; Hamilton Silva; Ana Cumano; Paulo Vieira
Journal:  J Exp Med       Date:  2005-03-14       Impact factor: 14.307

9.  Identification of proteoglycans as the APRIL-specific binding partners.

Authors:  Karine Ingold; Adrian Zumsteg; Aubry Tardivel; Bertrand Huard; Quynh-Giao Steiner; Teresa G Cachero; Fang Qiang; Leonid Gorelik; Susan L Kalled; Hans Acha-Orbea; Paul D Rennert; Jürg Tschopp; Pascal Schneider
Journal:  J Exp Med       Date:  2005-04-25       Impact factor: 14.307

10.  A critical role for induced IgM in the protection against West Nile virus infection.

Authors:  Michael S Diamond; Elizabeth M Sitati; Lindzy D Friend; Stephen Higgs; Bimmi Shrestha; Michael Engle
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  8 in total

Review 1.  Role of type I interferons in the activation of autoreactive B cells.

Authors:  Kerstin Kiefer; Michael A Oropallo; Michael P Cancro; Ann Marshak-Rothstein
Journal:  Immunol Cell Biol       Date:  2012-03-20       Impact factor: 5.126

2.  A role for 3-O-sulfated heparan sulfate in promoting human cytomegalovirus infection in human iris cells.

Authors:  John Baldwin; Erika Maus; Brian Zanotti; Michael V Volin; Ritesh Tandon; Deepak Shukla; Vaibhav Tiwari
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

3.  Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4.

Authors:  Bruno Frederico; Ricardo Milho; Janet S May; Laurent Gillet; Philip G Stevenson
Journal:  PLoS Pathog       Date:  2012-09-20       Impact factor: 6.823

4.  Analysis of KSHV B lymphocyte lineage tropism in human tonsil reveals efficient infection of CD138+ plasma cells.

Authors:  Farizeh Aalam; Romina Nabiee; Jesus Ramirez Castano; Jennifer Totonchy
Journal:  PLoS Pathog       Date:  2020-10-19       Impact factor: 6.823

Review 5.  Molecular Virology of KSHV in the Lymphocyte Compartment-Insights From Patient Samples and De Novo Infection Models.

Authors:  Farizeh Aalam; Jennifer Totonchy
Journal:  Front Cell Infect Microbiol       Date:  2020-12-04       Impact factor: 5.293

Review 6.  Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily.

Authors:  Kirstin Kucka; Harald Wajant
Journal:  Front Cell Dev Biol       Date:  2021-02-11

Review 7.  The Role of Latently Infected B Cells in CNS Autoimmunity.

Authors:  Ana Citlali Márquez; Marc Steven Horwitz
Journal:  Front Immunol       Date:  2015-10-28       Impact factor: 7.561

Review 8.  Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies.

Authors:  Amit Bar-Or; Michael P Pender; Rajiv Khanna; Lawrence Steinman; Hans-Peter Hartung; Tap Maniar; Ed Croze; Blake T Aftab; Gavin Giovannoni; Manher A Joshi
Journal:  Trends Mol Med       Date:  2019-12-17       Impact factor: 11.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.